Pain Phenotypes in Knee Osteoarthritis

June 14, 2016 updated by: University of Colorado, Denver

Determination of Pain Phenotypes in Older Adults With Knee Osteoarthritis

Recently, the medical community has learned damage to the knee joint may be one of many possible reasons for pain in knee osteoarthritis. Psychological factors and other aspects of brain function seem to play an important role in the pain experience. Although research studies have examined these factors on an individual basis, no study has examined all of these factors in the same population. Furthermore, some measures of brain function- having to do with perception of the painful body part- have yet to be examined in knee osteoarthritis. The investigators plan to study many of these variables in a group of people with knee osteoarthritis, as well in some healthy controls (without knee pain), in order to establish the relative importance of these measures in contributing to pain, as well as validate new measures of perception in people with knee osteoarthritis. We also plan to use a statistical tool- known as latent profile analysis- to look at subgroups of knee osteoarthritis pain. The hypothesis is that different people experience pain in knee osteoarthritis for different reasons. This study will be the first study to use all of these different variables- which can be reproduced in a clinical setting- to look for different subgroups of knee osteoarthritis pain. Ultimately, the goal is to help clinicians better prioritize and target interventions to individual patients. The investigators believe this will lead to better outcomes and fewer treatment complications currently associates with pharmaceutical and surgical interventions that are widely used to treat knee osteoarthritis.

Study Overview

Status

Completed

Detailed Description

In a 2011 statement to the Food and Drug Administration, the Osteoarthritis Research Society International (OARSI) identified the "phenotyping" of OA pain as a research priority to "better target pain therapies to individual patients." Successful identification of pain phenotypes will allow new interventions to be tested in homogeneous populations of patients presenting with similar pain pathophysiology, ultimately enhancing treatment effects in defined populations for whom interventions are determined safe and effective. Clinical populations of knee OA are clearly heterogeneous, spanning wide age ranges and encompassing patients with a wide variety of functional abilities. The pain experience in knee OA may be similarly individualized and complex; some patients may present with pain that appears attributable to classic signs of joint damage, while others may present with pain due to psychological distress or central mechanisms. Changes in somatosensory processing and pain threshold are also known to occur with aging. However, the scientific community has yet to examine these variables concurrently in the same study population. Therefore, the relative importance of each of these measures in determining pain severity across the lifespan is unknown. It is also unknown whether these variables (or interactions between variables) are representative of different pain phenotypes in knee OA. This is an important yet unresolved question; a patient with high levels of psychological distress and low levels of joint damage may warrant a different intervention strategy than the traditional knee-directed approach. On the other hand, someone with increased psychological distress in addition to severe joint damage may benefit from traditional interventions that are further augmented with other impairment-specific interventions. This sort of targeted approach is the topic of current research in other chronic pain populations, where a similar conceptual model, composed of peripheral, psychological and central components to the pain experience (among others), is recognized.

Study Type

Observational

Enrollment (Actual)

187

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Aurora, Colorado, United States, 80045
        • University of Colorado Denver, Anschutz Medical Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Study subject population will include 50-85 year olds who experience knee pain and have been diagnosed with knee osteoarthritis by a physician. Additionally, a healthy control cohort will be recruited. This cohort will also be 50-85 years old but will deny having any pain and will not be diagnosed with knee osteoarthritis.

Description

Inclusion Criteria:

  • Age 50-85
  • Diagnosed with Knee Osteoarthritis by a physician or by ACR clinical criteria

Exclusion Criteria:

  • sensory dysfunction due to injury (i.e. known nerve damage)
  • neurological diagnosis affecting sensory or motor function (e.g. stroke, Parkinson's Disease, multiple sclerosisetc.)

Healthy Volunteers eligibility criteria:

  • Age 50-85
  • Do not possess knee osteoarthritis diagnosis
  • do not have knee pain
  • do not have a history major knee trauma or lower extremity trauma or surgery
  • do not have any other pain condition

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Knee Osteoarthritis Cohort
Subjects with knee osteoarthritis will be asked to participate in the knee osteoarthritis testing session. This group will participate in 1 three hour testing session.
Questionnaire completion, strength testing, gait testing, pressure-pain threshold testing, proprioception testing, knee measurements, blood draw, and knee radiographs.
Healthy Subject Cohort
Healthy subjects will be asked to participate in the healthy control testing session. This group will participate in 1 two hour testing session.
Questionnaire completion, strength testing, gait testing, pressure-pain threshold testing, proprioception testing, and knee measurements.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Knee Pain Measured by Visual Analog Scale (VAS)
Time Frame: Baseline
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quadriceps Strength Testing with CSMI Humac Norm Isokinetic Dynamonmeter
Time Frame: Baseline
Baseline
Hamstrings Strength Testing with CSMI Humac Norm Isokinetic Dynamonmeter
Time Frame: Baseline
Baseline
Knee Range of Motion
Time Frame: Baseline
Baseline
Girth for Swelling Measurement of Knee
Time Frame: Baseline
Baseline
Tactile Threshold Test
Time Frame: Baseline
Baseline
Two Point Discrimination Test
Time Frame: Baseline
Baseline
Gait Speed Test
Time Frame: Baseline
Baseline
Five Time Sit-To-Stand
Time Frame: Baseline
Baseline
Pressure/Pain Threshold Test
Time Frame: Baseline
Baseline
Pressure/Pain Threshold Test Conditioned Pain Modulation
Time Frame: Baseline
Baseline
Laterality Recognition Test
Time Frame: Baseline
Baseline
Perception of Limb Size Test
Time Frame: Baseline
Baseline
Comorbidity Index
Time Frame: Baseline
Baseline
Intermittent and Constant Osteoarthritis Pain: Knee Version
Time Frame: Baseline
Baseline
KOOS Knee Survey
Time Frame: Baseline
Baseline
Arthritis Efficacy Scale
Time Frame: Baseline
Baseline
Tampa Scale for Kinesiophobia
Time Frame: Baseline
Baseline
Pain Catastrophizing Scale
Time Frame: Baseline
Baseline
Center for Epidemiologic Studies Depression Scale
Time Frame: Baseline
Baseline
Inflammatory Cytokines
Time Frame: Baseline
IL-1beta, IL-6, IL-8, TNF, C-Reactive Protein
Baseline
Kellgren-Lawrence Grade of Knee Radiographs
Time Frame: Baseline
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jennifer E Stevens-Lapsley, PT, PhD, University of Colorado, Denver

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2013

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

May 1, 2016

Study Registration Dates

First Submitted

December 18, 2015

First Submitted That Met QC Criteria

January 22, 2016

First Posted (Estimate)

January 27, 2016

Study Record Updates

Last Update Posted (Estimate)

June 16, 2016

Last Update Submitted That Met QC Criteria

June 14, 2016

Last Verified

June 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Knee Osteoarthritis

Subscribe